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IgG4-related disease (IgG4-RD) is an entity with various clinical manifestations. 
Histopathologically, it is characterised by lymphoplasmacytic infiltrates enriched in IgG4 (+) 
plasmacytes and usually fibrosis of the affected tissue. Most of the patients have also 
increased IgG4 serum levels and they respond to glucocorticosteroids. In children, due to its 
rare occurrence, IgG4-RD is ill defined. From the published studies, so far, it appears that 
ocular manifestations are very common in the paediatric population with IgG4-RD. Herein, 
we describe a new case of a child with IgG4-RD with ocular involvement manifested with 
orbit and eyelid swelling, successfully treated with steroids. In addition, we review the 
clinical, laboratory, histopathologic and radiologic characteristics of the published paediatric 
cases with IgG4-RD and ocular involvement, critically comparing them with the 
characteristics of the adult population. It seems that ocular manifestations are more 
frequently observed in children than in adults. Also, the pattern of involvement is different, 
with extraocular muscles and soft tissues being more commonly affected than the lacrimal 
glands. 
 










Since its first description in 2001, IgG4-related disease (IgG4-RD) has been increasingly 
recognised as an entity with many diverse clinical presentations [1] and a great mimicker of 
various  conditions [2]. It  is  characterized by  tumefactive tissue lesions,  usually  but not 
always, accompanied by increased IgG4 serum levels. Almost every organ could be affected, 
with the histopathologic hallmark of the disease being the lymphoplasmacytic infiltrates in 
which IgG4-positive plasma cells predominate. Fibrosis, usually of storiform pattern is also 
observed most of the times. Other histopathological characteristics such as obliterative 
phlebitis and eosinophils are also occasionally present [3]. 
 
IgG4-related ocular involvement/disease (IgG4-ROD) is a rather frequent manifestation 
encountered in about 17-23% of patients with IgG4-RD, however, not many studies have 
been published [4-6]. Every part of the orbit and ocular adnexa could be affected, including: 
lacrimal glands, orbital soft tissues, extraocular muscles, eyelids, optical and trigeminal 
nerves, bones and sclera [4,5] . 
 
Due to its rare occurrence, IgG4-RD in the paediatric population is ill defined so far and is 
unknown whether it shares the same clinical, serological and histopathological features with 
those observed in adults. According to a recent systemic literature review, it seems that 
ocular manifestations are very common (44%) amongst children with IgG4-RD [7]. 
 
Herein, we describe a young boy with IgG4-RD and ocular involvement and we review all 
published paediatric IgG4-RD cases with ocular manifestations, describing their 





A four-year-old boy was referred to the paediatric rheumatology clinic with a two-month 
history of orbital and upper right eyelid swelling without pain. His past medical history was 
unremarkable, while his maternal grandfather suffered from myositis and thyroiditis 
Hashimoto. 
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On physical examination, ptosis and swelling of the upper right eyelid were evident. His 
visual acuity, movement of the eyes, as well as fundoscopic examination were normal. 
 
Differential diagnosis included infectious diseases, vasculitis, sarcoidosis, malignancies, 
idiopathic orbital inflammation (IOI), orbital benign lymphoid hyperplasia (OBLH) and IgG4- 
RD with ocular manifestations. 
 
Laboratory investigation including whole blood test, acute phase reactants, biochemical 
analysis, thyroid function and urine test, were all within normal limits. Infectious diseases, 
sarcoidosis  and  neuroblastoma  were  ruled  out.  Anti-neutrophil cytoplasmic (c-ANCA,  p- 
ANCA), antinuclear, anti-double stranded DNA, Extractable Nuclear Antigen antibodies and 
rheumatoid factor were all negative. C3 and C4 serum levels, immunoglobulin 
electrophoresis and serum immunoglobulins were all within normal limits, apart from the 
elevated IgG4 levels: 222mg/dl, [normal value for a 4-year old boy: (1-189) mg/dl]. 
 
Brain Magnetic Resonance Imaging (MRI), orbit MRI and Computerized Tomography (CT). 
revealed a diffuse extraconal lesion with intermediate signal intensity in T1w and T2w 
images, and homogeneous contrast enhancement, at the superior-lateral part of the right 
orbit. A moderate swelling of the right lateral rectus muscle was also noted. The lacrimal 
gland, the superior rectus muscle and the superior oblique muscle were also involved. No 
intracranial extension or bone erosion was observed (Figure -1). The remaining  extraocular 
muscles, the optical nerves and the chiasm were normal and appeared unremarkable. 
 
Biopsy was obtained from the superior-lateral part of the right orbit and the lacrimal gland. 
It showed fibro-adipose tissue and dacryoadenitis, respectively. The inflammatory infiltrates 
of the latter were composed of lymphocytes, histiocytes and eosinophils. In the fibro- 
adipose tissue, storiform fibrosis and dense lymphoplasmacitic infiltrates were observed. In 
a single focus, IgG4 staining demonstrated the presence of more than 10 IgG4-positive 
plasma cells/hpf with a IgG4/IgG ratio>50%. Eosinophils were also present. Granulomas or 
evidence of vasculitis, lymphoproliferative disease or other neoplasms were not detected. 
 
Based on the clinical picture, the laboratory findings and the histopathological findings, the 
diagnosis of IgG4-related disease with ocular manifestations was undertaken. The patient 
was treated with prednisolone (0.5 mg/kg) for two months followed by slow tapering. Four 
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In the adult population, data available from big IgG4-RD registries, investigating the 
frequency of ocular manifestations in IgG4-RD, support that IgG4-ROD is being encountered 
in about 17-23% of the patients [4-6]. In accordance with other retrospective published 
studies, it seems also that IgG4-ROD could be the diagnosis in patients previously thought to 
have idiopathic orbital inflammation (IOI) or orbital benign lymphoid hyperplasia (OBLH) in 
about 5-23% and 40-50%, respectively [8]. Many different criteria have been used by the 
investigators for the diagnosis of IgG4-ROD. These include: Consensus diagnostic criteria 
[IgG4   (+)   plasmacytes   >100/hpf   and   IgG4(+)/IgG(+)   ratio>40%]   [3],   Comprehensive 
diagnostic criteria [IgG4 (+) plasmacytes >10/hpf and IgG4(+)/IgG(+) ratio>40%] [9] and the 
Japanese Study Group criteria for IgG4-related ophthalmic disease [IgG4 (+) plasmacytes 
>50/hpf and IgG4(+)/IgG(+) ratio>40%] [10]. 
 
 
Males seem to be more commonly affected compared to females [4,5]. Involvement is 
bilateral in more than 60% of the patients with IgG4-ROD [4-6] while extraophthalmic 
manifestations are found in about 70-80% of the patients [4-6]. Lacrimal gland is the most 
frequently affected part followed by extra-ocular muscles and soft tissues involvement. In 
about 10% of the patients trigeminal or optic nerves are affected. Also, in a minority of 
patients, bone involvement is evident usually manifested as bone remodelling rather than 
destruction [4-6]. Presenting symptomatology of IgG4-ROD may include: orbital mass/eyelid 
swelling, proptosis, pain, reduction of visual acuity, diplopia and restriction of eye 
movements [6]. As observed generally in IgG4-RD patients, about one-third of IgG4-ROD 
patients appear to have normal IgG4 serum levels [4,5]. From a histopathological point of 
view, they are characterized by lymphoplasmacytic infiltrates and fibrosis. Eosinophils are 
also  occasionally  present.  Interestingly,  in  these  patients,  the  characteristic  storiform 
pattern is not described consistently amongst different investigators and it seems to be 
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more pronounced only in biopsies obtained from affected lacrimal glands [4-6,11]. In 
addition, obliterative phlebitis appears to be a rather uncommon finding, although this 
might be confounded by the small size of eye vessels [12]. Most of the patients respond to 
treatment with steroids, however about 2/3 of them relapse [4-6]. As for other IgG4-RD 
manifestations, steroid-sparing agents, may be used as induction therapy, along with 
steroids, or as treatment for relapse. Rituximab seems also to be a good alternative in the 








IgG4-RD is increasingly being described in the paediatric population [7]. Interestingly, 
amongst these patients, ocular involvement was by far the most commonly reported 
manifestation, reaching 44%, according to a recent systemic literature review [7]. 
 
Until September 2017, to the best of our knowledge, 13 cases -10 females and 3 males- of 
children with ophthalmic manifestations have been described [13-22]. The most common 
symptomatology  was  unilateral  protrusion/swelling  (11/13,  84.6%),  while  eyelid 
involvement was also mentioned in 6/13 (46.1%) cases (Table-1). Interestingly, only 3/13 
(23.1%)   presented   extra-ophthalmic   manifestations   and   other   two   had   history   of 
ophthalmic disease (preseptal cellulitis, uveitis and retinopathy of prematurity). 
 
Serum IgG4 levels were found to be increased in 5/13 (38.5%) of the patients, inflammation 
markers in 3/6 (50%), while autoimmune profile was negative in all the patients for whom 
data were available (Table-1) 
 
Clinical findings and imaging studies, in these patients, suggested “orbital mass” as the most 
common  finding.  Extraocular  muscle  involvement  and  bone  involvement   were  also 
described in 7/13 (53.8%) and 3/13 (23.1%) cases, respectively. A case with optic nerve 
sheath  enhancement,  amongst  other  findings,  has  also  been  described.  Interestingly, 
lacrimal gland involvement has been observed in only two children so far (Table-2). 
 
Histopathologically,  the  cases  described  were  characterized by  lymphoplasmacytic 
infiltrates. Fibrosis was referred in 6/11 (54.5%) of the available biopsies with storiform 
pattern being present in only one. Obliterative phlebitis was also present in two cases. 
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Number  of  IgG4-positive  plasmacytes/hpf  ranged  from  14  to  more  than  150  and  the 
 
IgG4/IgG ratio ranged from 30 to 60 % (Table-2). 
 
 
The vast majority of the patients were initially treated with steroids (by mouth or 
intravenously) with or without steroid-sparing agents, such as methotrexate or 
mycophenolate mofetil. Eight out of 11 patients, (72.8%), for whom data were available, 
relapsed or didn’t respond and they were retreated with other immunosuppressants such as 
azathioprine, mycophenolate mofetil, cyclophosphamide, rituximab in 3 cases and anti-TNF 








Ocular manifestations in the context of IgG4-RD have been described in the adult population 
in big IgG4-RD registries and from pooled analyses of the published literature. However, in 
the paediatric population IgG4-RD is not well described and possibly underdiagnosed. 
 
Differential diagnosis of IgG4-ROD includes lymphoproliferative disorders, granulomatosis 
with polyangiitis, sarcoidosis, tuberculosis, infections, thyroid eye disease, malignancies, 
idiopathic orbital inflammation (IOI), orbital benign lymphoid hyperplasia (OBLH), 
xanthogranulomas, Erdheim-Chester disease and Rosai-Dorfman disease. Importantly, 
lymphoma needs to be thoroughly excluded as it is a great mimicker of IgG4-ROD and could 
have positive staining for IgG4 plasmacytes [6]. 
 
In this article, we reviewed the paediatric cases published with IgG4-ROD and we present 
also one new case of a child with IgG4-ROD. 
 
From  the  cases  described  up  to  August  2017,  it  seems  that  IgG4-ROD  in  paediatric 
population has some striking differences compared to that of adults. Firstly, frequency of 
ophthalmic manifestations is higher in children. Secondly, the pattern of ocular involvement 
differs. In children, involvement is usually unilateral. Orbital soft tissue and extraocular 
muscles are the most common affected sites, whilst lacrimal glands have been very 
infrequently described to be involved. Extra-ophthalmic manifestations are also rare in 
children with IgG4-ROD. 
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Histopathological findings include lymphoplasmatic infiltrates with associated fibrosis. 
Storiform pattern is not commonly observed, possibly reflecting the fact that lacrimal glands 
are not so commonly involved. Besides, as mentioned above, the frequency of storiform 
pattern in IgG4-ROD adult population remains as a matter open for discussion. IgG4-ROD in 
children, as described in adults is steroid responsive. A significant proportion of patients will 
relapse and need additional treatment with steroid sparing agents. Rituximab and anti-TNF 
have also been described to have good results in such patients. 
 
In our case, we present a young boy with unilateral eye involvement. The presenting 
manifestation was eyelid and orbital swelling. MRI findings revealed diffuse soft tissue 
swelling and extraocular muscle involvement as well. Infectious diseases, other autoimmune 
diseases and thyroid dysfunction were thoroughly excluded. Macroscopically, the affected 
tissue was sclerotic and biopsy did not display any findings consistent with malignancy, 
lmphoproliferative or granulomatosous disease. Interestingly IgG4 (+) plasmacytes >10/hpf, 
and high IgG4/IgG ratio were identified in a single spot. Besides significant fibrosis and 
eosinophils were identified. 
 
We acknowledge that our review has some certain limitations. Firstly, it is based on a 
retrospective analysis of published cases. Secondly, the number of paediatric reports 
described so far with ocular involvement is too small to draw a safe conclusion. Thankfully, 
we had access to the full papers of reported cases, so all available data were reviewed. 
Moreover, in our case, IgG4-positive plasmacytes were recognized in a single spot. It is 
unclear to which extent IgG4-positive plasmacytes should be present to place the diagnosis 
of IgG4-RD. However, the exclusion of other possible diagnoses, the clinical and laboratory 
features, the steroid responsiveness and the high IgG4/IgG ratio, along with fibrosis and 
eosinophils in the tissue, make the diagnosis most probable. Besides, the number of IgG4- 
positive  plasmacytes  needed  to  place  the  diagnosis  of  IgG4-ROD  is  still  not  defined, 
especially in the paediatric population. 
 
IgG4-RD is an entity, very recently described. Over the two last decades, significant efforts 
have been made towards the description of its clinical, serological and histopathological 
features. There are still however many issues to be clarified. Amongst them, it is the natural 
history of IgG4-RD and its various manifestations in children. 
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Fig 1. A. Coronal T1 weighted image. B. Gadolinium-enhanced coronal T1 weighted image. C. 
Gadolinium-enhanced fat- suppressed axial T1 weighted image. Extraconal lesion at 
the superior-lateral part of the right orbit (arrows), with low signal intensity, 
presenting  homogeneous  contrast  enhancement.  A  moderate  swelling  of  the 
superior and lateral rectus muscles was noted 
